Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
6,300,475
-
Share change
-
-980,099
-
Total reported value
-
$12,723,000
-
Put/Call ratio
-
26%
-
Price per share
-
$2.02
-
Number of holders
-
21
-
Value change
-
-$2,024,499
-
Number of buys
-
11
-
Number of sells
-
11
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q3 2020
As of 30 Sep 2020,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,300,475 shares.
The largest 10 holders included
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, STONEHILL CAPITAL MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, HEARTLAND ADVISORS INC, MORGAN STANLEY, CITADEL ADVISORS LLC, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, HRT FINANCIAL LP, and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM.
This page lists
21
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.